Actively Recruiting

Age: 2Months - 65Years
All Genders
Healthy Volunteers
ID04034264

Characterization of Febrile Disease Landscape in Cambodia Using Metagenomic Pathogen Sequencing

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-04-08

6500

Participants Needed

6

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating vector-borne diseases, which are infections caused by bites from mosquitoes, flies, fleas, ticks, or other blood-feeding insects. These diseases contribute to nearly one million deaths annually and are increasing, especially in Southeast Asia. This study aims to better understand these illnesses in Cambodia, where they may account for about 10% of fevers, by identifying pathogens using advanced metagenomic sequencing techniques. Participants include people aged 2 months to 65 years who have a fever of at least 38 degrees Celsius or have been diagnosed with important infectious pathogens. Close contacts of infected individuals may also join. Participants provide information about their health, travel, sex, age, and residence. Blood samples are collected, and nasal swabs are taken if respiratory symptoms are present. Optional follow-up blood samples and nasal swabs may be taken within 1-2 weeks and/or up to 3 months after enrollment. During the study, participants complete questionnaires and undergo medical history screening. Children are weighed to ensure suitability for blood sampling. The researchers will analyze pathogen sequences from samples collected between day 0 and 2 of enrollment and assess immune reactions to insect saliva. This study includes long-term tracking through optional follow-up samples to better understand disease spread and impact in the region.

CONDITIONS

Brief Title

Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing

Who Can Participate

Age: 2Months - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Provide signed and dated informed consent.
  • Willing to follow all study procedures.
  • Male or female aged between 2 months and 65 years.
  • Meet one of these: fever of 38 degrees Celsius or higher in the last 24 hours, confirmed infection with a specified pathogen, or afebrile close contact of an infected individual.
  • Agree to allow storage of biological samples and de-identified sequencing data for future research.
Not Eligible

You will not qualify if you...

  • Have any chronic or current medical condition that may interfere with study participation.
  • Have had surgery within the last month if currently febrile.
  • Enrolled and exited the study within 30 days for febrile patients or within 14 days for afebrile close contacts.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - Enrollment (between Day 0-2)

Participants provide biological samples that are analyzed using novel genomics technologies to identify possible infectious causes of febrile illness or exposure to pathogens.

1 to 2 visits depending on participant group

Long-term Monitoring

Duration - Duration varies depending on pathogen detection and participant status

Participants who test positive for highly transmissible or highly virulent pathogens and their close contacts are followed up with additional sample collection and testing to better understand disease burden.

Additional follow-up visits as needed

Trial Site Locations

Total: 6 locations

1

Kampong Speu Referral Hospital

Chbar Mon, Cambodia

Actively Recruiting

2

Kantha Bopha Hospital

Phnom Penh, Cambodia

Actively Recruiting

3

Khmer-Soviet Friendship Hospital

Phnom Penh, Cambodia

Actively Recruiting

4

National Pediatric Hospital

Phnom Penh, Cambodia

Actively Recruiting

5

Preah Kossomak Hospital

Phnom Penh, Cambodia

Actively Recruiting

6

Takeo District Referral Hospital

Takeo, Cambodia

Actively Recruiting

Loading map...

Research Team

C

Christina C Yek, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Report from the 'One Health' 9th Tick and Tick-Borne Pathogen Conference and the 1st Asia-Pacific Rickettsia Conference, Cairns, Australia, 27th August-1st September 2017.

Ala Tabor, Manuel Rodriguez Valle

https://pubmed.ncbi.nlm.nih.gov/30279400